About US
Contact us
-
AstraZeneca’s Movantik receives FDA approval to treat OICAstraZeneca has received approval from the US Food and Drug Administration (FDA) for its Movantik (naloxegol) tablets C-II to treat opioid-induced constipation (OIC) in adult patients with chronic non2014/9/24
-
Gilead’s Zydelig gets marketing approval from European Commission for incurable blood cancersUS-based Gilead Sciences has received marketing authorisation from the European Commission for its Zydelig (idelalisib) 150mg tablets to treat two incurable blood cancers, chronic lymphocytic leukemia2014/9/23
-
Sun Pharma and Merck partner for plaque psoriasis drug candidate tildrakizumabIndia-based Sun Pharma has signed an exclusive worldwide licensing agreement with US-based Merck for its investigational therapeutic antibody candidate, tildrakizumab (MK-3222). Tildrakizumab is a hu2014/9/23
-
GSK to pay £297m fine over bribery case in ChinaGlaxoSmithKline (GSK) has been fined £297m by the Changsha Intermediate People's Court in Hunan Province, China, over bribery charges. The fine follows after GSK China Investment (GSKCI) was fo2014/9/22
-
Bayer brings $12.9B plastics spinoff to Big Pharma's slim-down partyBayer's drug business is booming. So much so that the German company has decided to put its focus squarely on its life sciences division: It plans to spin off its plastics unit within 18 months, takin2014/9/19
-
FDA backs ED upstart Stendra as a fast-acting alternative to ViagraIt's no picnic competing with a cultural phenom. Auxilium ($AUXL) and Vivus ($VVUS) know this well: Their new erectile dysfunction pillStendrahas to go up against Pfizer's ($PFE)Viagra. Competition fr2014/9/19
-
The FDA approved a new opioid-induced constipation treatment from partners AstraZeneca ($AZN) and Nektar Therapeutics ($NKTR)The FDA approved a new opioid-induced constipation treatment from partners AstraZeneca ($AZN) and Nektar Therapeutics ($NKTR), shaking off some safety concerns and green-lighting a drug the two hope c2014/9/18
-
Sutro Biopharma has landed another marquee name for its list of development partners for antibody-drug conjugates.Sutro Biopharma has landed another marquee name for its list of development partners for antibody-drug conjugates. Merck KGaA, which has been struggling in the clinic for years, has signed on with the2014/9/17
-
ROQUETTE China Launches Chinese Website(September16, 2014, Shanghai, China) ROQUETTE China is inviting visitors to explore its Chinese website. The new website was developed to provide the ultimate user-friendly experience with improved na2014/9/16
-
Meet Baxalta, the pharma spinoff Baxter plans to unleash in 2015When Abbott Laboratories ($ABT) told the world that its spun-off pharma business would bear the AbbVie ($ABBV) moniker, there were the usual marketing-speak explanations. Includes the name of its form2014/9/12